Location History:
- Ann Arbor, MI (US) (1995 - 1999)
- Durham, NC (US) (2000 - 2015)
Company Filing History:
7 out of 3,385 
2 out of 2 
1 out of 1 Years Active: 1995-2015
Title: Brian Keith Shull: Innovator in Glycoside Derivatives
Introduction
Brian Keith Shull is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis and application of glycoside derivatives. With a total of 13 patents to his name, Shull's work has the potential to impact drug delivery systems and treatment methodologies.
Latest Patents
Among his latest patents, Shull has developed methods and compositions for the synthesis, production, and use of pro-drug propofol analogs. This invention focuses on a method for producing a broad group of glycosylated propofol carbohydrate derivatives. Additionally, he has worked on glycosylated valproic acid analogs, which are designed to improve solubility and enhance drug delivery for various diseases.
Career Highlights
Shull has had a distinguished career, working with reputable institutions such as the University of Michigan and Nutek Pharma Ltd. His innovative approaches have garnered attention in the pharmaceutical industry, showcasing his expertise in drug development.
Collaborations
Throughout his career, Shull has collaborated with esteemed colleagues, including Masato Koreeda and Roeland J Tuinman. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Brian Keith Shull stands out as a prominent inventor in the field of glycoside derivatives, with a focus on improving drug delivery systems. His contributions through his patents and collaborations continue to influence the pharmaceutical landscape.